The Sensex surged by 1859.88 points, opening at a record 75,821.19....
Category:
Eco/Invest/Demography
Latest
Markets may reach new heights on Monday, but investors should invest for long term in quality stocks
Porinju Veliyath, Founder - Equity Intelligence noted that there...
Sweltering heat directs attention at ‘disappearing’ spring in country
Such extreme heat has wide-ranging consequences on public health,...
10 crore Indians’ card data selling on Dark Web: Researcher
“On August 18, 2020, an unauthorised attempt on our servers was detected and terminated when in progress. No card numbers, financial credentials or transaction data were compromised,” a spokesperson of JusPay said in a statement.
As end to pandemic mask-wearing nears, South Koreans scramble to arrange cosmetic surgery in the future
“Both surgical and non-surgical inquiries about eyes, eyebrows, nose bridge and foreheads – the only visible parts – certainly increased,” said Park Cheol-woo, a surgeon at WooAhIn Plastic Surgery Clinic, who was in charge of Ryu’s operation.
India bars virus vaccine maker from exporting
The company also has been barred from selling the vaccine on the private market.
As a result, Adar Poonawalla, Serum Institute’s CEO said, the export of vaccines for COVAX — the ambitious initiative created to ensure equitable access to COVID-19 vaccines set up by the World Health Organization, vaccines alliance GAVI and CEPI, a global coalition to fight epidemics — won’t begin until March or April.
5% obligatory cession for GIC Re in general insurance business to continue in 2021-22:IRDA
Percentage of commission on obligatory cession for different classes of business will be as follows:
i) Minimum 5% for Motor TP and Oil & Energy insurance.ii) Minimum 10% for Group Health insurance iii) Minimum 7.50% for Crop Insurance.iv) Average Terms for Aviation insurance.
v) Minimum 15% for all other classes of insurance business.
Bharat Biotech says approved COVID shot trials ‘honest’
Health Minister Harsh Vardhan clarified on Twitter on Sunday that the emergency use approval for COVAXIN was “in clinical trial mode”, wherein all recipients of the vaccine would be tracked and monitored as if they were in trial.
2020 was 8th warmest year since 1901, past two decades saw highest temperature rise: IMD
The IMD said the past two decades — 2001-2010 and 2011-2020 — were also the warmest decades on record with anomalies of 0.23 degree Celsius and 0.34 degree Celsius respectively, indicating the overall rising temperature.
Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII
“We want the vaccine to be affordable and accessible to all. The government of India will receive it at a far more affordable price of USD 3-4, since they will be buying in a larger volume,” said Adar Poonawalla,CEO,Serum Institute of India,
Sufficient Covid-19 Vaccines For First Phase Of Vaccination Drive: V K Paul
“Our first phase (of vaccination) comprises priority groups with a high risk of mortality and our healthcare and frontline workers. For them, we believe, we have enough (Covid-19 vaccine) stockpile,” V K Paul,Chairman of National Expert Group On Vaccine Administration for Covid-19, told PTI in an interview.
Labour Min seeks feedback on draft model standing orders for manufacturing, mining, service sectors
To provide safeguard to the IT industry, “involvement in unauthorised access of any IT system, the computer network of the employer/ customer/client has been prescribed as misconduct, according to the draft orders.
Approval for vaccines accelerates India”s journey to be COVID-free, says Modi
In a series of tweets after the Drugs Controller General of India (DCGI) approved Oxford”s vaccine Covishield and Bharat Biotech”s Covaxin for restricted emergency use, Modi said it will make every Indian proud that both the vaccines are made in India.